Highlights
The pCM1.1_luc_hygro vector contains a minimal promoter followed by a luciferase The plasmid pCM1.1_ NF-κB _luc_hygro was introduced into RAW 264.7 cells 148 glutamine, and 150 μg/ml hygromycin B). After being selected for 3 weeks, 6 hygromycin-resistant cells were then cloned by limited dilution to obtain a single cell 150 clone and were then screened for the induction of luciferase activity by treatment with 151 gradient concentrations of LPS (e.g. 1000 ng/ml, 100 ng/ml, and then 1:3 dilutions, 10 152 series). The resulting positive clones were routinely maintained in the selective media. activity. The dose-response curves at different cell passages were relatively parallel.
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These results indicate that LPS had the best and most stable dose-effect relationship
258
with NF-κB activity at a cell density of 10×10 5 cells/ml. The results are presented in Figure 6 . The data show a good linear relationship 288 between the expected and measured concentrations in the tested LPS concentration 289 range (1.5-12.0 EU/ml), suggesting that the method also had good accuracy. Table 2 , and they indicate that the method has 295 potential for various applications. Drugs were tested at their MVD, each of which was calculated as the endotoxin limit 301 concentration in EU/ml divided by the LOD (in this case, 0.5 EU/ml).
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Each drug presented five blinded spikes, two of which were defined as negative, 16 meaning they were below 0.5 EU/ml (0 and 0.25 EU/ml), while three were positive 304 (0.5, 1.0, and 2.0 EU/ml). These spikes were tested by both the RGA and BET.
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After the interference test was passed, the samples were classified by a so-called Table 3 . 
